Royalty Report: Medical, Diagnostic, Delivery – Collection: 299262

License Grant

University grants
—  an exclusive, worldwide right and license to use University Technology, and to make, have made, use, import, export, sell and offer to sell Licensed Products incorporating, made, using or derived from University Technology, upon the terms and conditions of this Agreement.
—  grants to Licensee an exclusive , worldwide license under the Patent Rights to make, have made, use, import, export, sell and offer to sell Licensed Products, and to practice any process, method or procedure covered by the Patent Rights, upon the terms and conditions set forth herein.

For the Background Technology, University grants a non-exclusive worldwide right and license under any intellectual property or propriety rights of University and to which University has the right to license to the extent necessary for Licensee to: practice any process, method or procedure covered by the Patent rights; or otherwise use any University Technology to make, have made, use, import, sell and offer to sell Licensed Products as set forth herein.

For Therapeutic Use, During the term of the Research Agreement, Licensee shall have the option to obtain from University an exclusive, worldwide right and license to use any invention relating to POAG which has been developed in the Laboratory and which relates to therapeutic approaches to POAG and which University has the right to provide to Licensee.

License Property

University has rights or has invented technology for genetic-based prognosis and diagnosis of Adult Onset Primary Open Angle Glaucoma (POAG).

Primary open-angle glaucoma (also, primary glaucoma, chronic glaucoma) refers to slow clogging of the drainage canals resulting in increased eye pressure which causes progressive optic nerve damage.

The Invention patent is titled Identification of the adult onset primary open angle Glaucoma gene.

Licensed Products means any method, procedure, process, prognostic kit, diagnostic kit, product, or component part thereof whose manufacture, sale or use includes a material use of UniversityTechnology or Patent Rights for the prognosis and/or diagnosis of POAG.

Field of Use

Licensee is an ophthalmic product development company focused on developing genetically based tools, for the diagnosis, prognosis and management of glaucoma, as well as other ophthalmic pharmaceutical products based on proprietary eyedrop-based drug delivery technology, and has retinal programs which include both a therapeutic agent and a retinal drug delivery technology.

License Grant

University grants the exclusive worldwide right and license to make, have made, use, import, export, lease and sell the Licensed Products, and to practice the Licensed Processes to the end of the term for which the Patent Rights are granted unless sooner terminated according to the terms hereof.

License Property

The University has patents for Intraretinal Delivery System.  The license relates to a patented device for the controlled, non-surgical delivery of ophthalmic drugs to the retina and other tissues in the posterior chamber of the eye.

Field of Use

Licensee develops genetically-based tools for the diagnosis and prognosis of glaucoma, ophthalmic, and pharmaceutical products based on its proprietary eyedrop-based drug delivery technology, and, the Company licensed a device for the delivery of drugs to the retina.

License Grant

Licensor grants to a Swedish Licensee an exclusive sublicense, with reversion rights and research rights reserved to Licensor, of all of its rights under the ISV-900 Project Agreements.

Licensor assigns all of its rights, title and interest in the Licensor Know-How.

Licensor grants to Licensee an exclusive right and license under the ISV-900 Technology during the Term to develop, have developed, make, have made, import, have imported, distribute, have distributed, commercialize, have commercialized, market, have marketed, sale, and have sold the Product by Licensee, its Affiliates or Sublicensees in the Territory.

Licensor grants to Licensee an exclusive right and license to use the Trademarks during the Term solely for the purpose of marketing, selling, having sold and distributing Product in the Territory.

License Property

The ISV-900 Technology and Patents are for the Diagnosis, Treatment and Prognosis of Glaucoma.

Licensors Know-How means any Know-How of Licensor or its Affiliates relating specifically to the ISV-900 Genes that is developed or owned by Licensor as of the Effective Date or that comes into existence during the Term.  Licensor Know-How does not include ISV-900 Know-How or ISV-900 Patents.

ISV-900 Genes means the TIGR gene, Apolipoprotein E gene and CYP1B1 gene and all polymorphisms, mutations and variations thereof. ISV-900 Know-How means all Know-How developed pursuant to the ISV-900 Agreements. ISV-900 Know-How does not include ISV-900 Patents or Licensor Know-How.

Licensor owns or Controls or will own or Control certain patents, patent applications, trademarks, registrations, market applications and know-how related to the Product, and it has or will have the right to grant certain rights and sublicenses.

Trademark means those trademarks, trade names, brand names, logos and designs whether registered or not, owned or Controlled by Licensor.

Field of Use

The field means the use in the diagnosis, prognosis and treatment of human diseases and/or disorders based on the research, development and/or use of the ISV 900 Genes.